News
Category
-
PR Newswire
Quartet Health Acquires InnovaTel Telepsychiatry, Making Shared Vision of Speed to Quality Mental Health Care for All a Reality
December 13, 2021 -
GlobeNewswire
Acacia Pharma Announces Successful Completion of BARHEMSYS® Post-approval Requirement Study in Patients with Severe Renal Impairment
December 13, 2021 -
GlobeNewswire
Adagene Presents Preclinical Data Showcasing Best-in-Class Profiles for ADG153, an Anti-CD47 SAFEbody® and ADG152, a CD20xCD3 Bispecific T-cell Engager POWERbody™
December 13, 2021 -
FierceHealthcare
Quartet picks up InnovaTel Telepsychiatry to expand its reach in the digital mental health market
December 13, 2021 -
GlobeNewswire
Beam Therapeutics Outlines Long-term Strategy for Base Editing Programs in Sickle Cell Disease and Provides Preclinical Data Updates at ASH
December 12, 2021 -
GlobeNewswire
Carrot Fertility Expands Executive Team, Hires Former Aetna Executive as Chief Commercial Officer
December 9, 2021 -
PR Newswire
1upHealth Named as “Most Innovative Digital Health Startup” by CB Insights’ Digital Health 150
December 9, 2021 -
MobiHealthNews
Quartet Health snaps up fellow mental health company InnovaTel Telepsychiatry
December 9, 2021 -
PR Newswire
Proximie Partners with Jhpiego in New Initiative to Improve Obstetric Surgical Care
December 9, 2021 -
Endpoints News
Atlas, F-Prime launch K36 Therapeutics to advance oncology molecule for elusive epigenetic target
December 9, 2021 -
Business Wire
NOCD Named to the 2021 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups
December 8, 2021 -
Business Wire
HealthEdge Completes Acquisition of Wellframe
December 7, 2021 -
Business Wire
Ochsner Health Makes Finding the Right Provider Easier with Solutions from Kyruus
December 7, 2021 -
PR Newswire
Stride partners with 100+ flexible work platforms and employers in support of “Gig Workers’ Week of Action” to boost health insurance enrollment before Dec. 15th deadline
December 6, 2021 -
PR Newswire
Nature Medicine Publishes Results from Two Registration Studies of AYVAKIT® (avapritinib) Showing Sustained Benefits in Patients with Advanced Systemic Mastocytosis
December 6, 2021 -
Business Wire
CF Foundation Invests $3.5 Million in Pulmocide for Development of Novel Antifungal Treatment for Lung Transplant Recipients
December 6, 2021 -
PR Newswire
Even Financial Named to The 2021 Deloitte Technology Fast 500™
December 3, 2021 -
PR Newswire
Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications
December 2, 2021 -
PR Newswire
Independence Health Group and Quartet Health Announce Strategic Partnership to Drive Speed to Mental Health Care
December 2, 2021 -
PR Newswire
Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications
December 2, 2021 -
GlobeNewswire
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
December 2, 2021 -
AviadoBio
AviadoBio™ Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform
December 2, 2021 -
Business Wire
Fiverr Teams Up With Stride Health to Help Fiverr Community Access Affordable Healthcare
December 1, 2021 -
Business Wire
Rallybio Reports Positive Data in Its Clinical Program for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
December 1, 2021 -
GlobeNewswire
Surface Oncology Announces FDA Clearance of IND Application for GSK4381562, a Novel Antibody Targeting PVRIG
December 1, 2021 -
GlobeNewswire
Ultragenyx Announces First Patient Dosed in Phase 1/2 Clinical Study of UX053, an mRNA Therapy for the Treatment of Glycogen Storage Disease Type III
December 1, 2021 -
PR Newswire
Avivomed Raises $32 Million in Series A Financing
December 1, 2021 -
PR Newswire
Insilico Medicine Initiates First-in-Human Study of ISM001-055, a Novel Drug Discovered Using Insilico’s Proprietary End-to-end Artificial Intelligence Platform
November 30, 2021 -
Business Wire
Turnstone Biologics Announces Research Collaboration with Moffitt Cancer Center to Advance Novel TIL Immunotherapies for Solid Tumor Indications
November 29, 2021 -
GlobeNewswire
Adagene Announces FDA Clearance of IND for Phase 1b/2 Trial of Anti-CTLA-4 Monoclonal Antibody ADG116 in Combination Therapy with Anti-PD-1 Antibody Pembrolizumab
November 29, 2021 -
GlobeNewswire
Verve Therapeutics Appoints Allison Dorval, Experienced Financial Executive, as Chief Financial Officer
November 29, 2021 -
GlobeNewswire
Ultragenyx Announces Additional Positive Multi-Year Durability Data from Phase 1/2 AAV Gene Therapy Studies
November 29, 2021 -
FierceBiotech
Cloud R&D developer Benchling picks up second nine-figure venture capital haul this year
November 19, 2021 -
GlobeNewswire
Tempest Announces First Patient Dosed with TPST-1495 in Combination with Pembrolizumab
November 18, 2021 -
TechCrunch
OTA Insight books $80M for its hospitality business intelligence tools, used by 55K hotel properties globally
November 18, 2021 -
Owkin
Owkin becomes ‘unicorn’ with $180m investment from Sanofi and four new collaborative projects
November 18, 2021 -
GlobeNewswire
Orchard Therapeutics Announces New England Journal of Medicine Publication of Interim Proof-of-concept Study Results of OTL-203 for Hurler Syndrome
November 18, 2021 -
Business Wire
WellAir Launches New Air Cleaning Device That Is 99.9% Effective Against Indoor Airborne Pathogens
November 17, 2021 -
GlobeNewswire
Cytek® Biosciences Marks Milestone Achievement with Shipment of 1000th Cell Analysis System
November 17, 2021 -
GlobeNewswire
BenchSci Named a Deloitte Technology Fast 50™ Company as Impact on Drug Discovery Grows
November 17, 2021 -
GlobeNewswire
Denali Therapeutics Announces Strategic Partner Takeda Exercises Option to Co-Develop and Co-Commercialize DNL593 (PTV:PGRN)
November 17, 2021 -
GlobeNewswire
Recurly to Exceed $10 Billion in Transaction Payment Volume as Pay-As-You-Go Subscription Models Accelerate
November 17, 2021 -
GlobeNewswire
iVest+ Announces Integration with Tradier to Serve Its Expanding Active Trader Community
November 16, 2021 -
PR Newswire
Embark sponsors The National Dog Show, in commitment to improving life and longevity of all dogs
November 16, 2021 -
PR Newswire
FDA Grants AppliedVR Approval for First Virtual Reality Therapeutic to Treat Chronic Low Back Pain
November 16, 2021 -
PR Newswire
Innovent Announces the Results of the Phase Ib Clinical Trial of IBI302, a First-in-class Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2021 American Academy of Ophthalmology
November 14, 2021 -
GlobeNewswire
Tempest Presents Data Supporting the Dual Mechanism of TPST-1495 as an Optimal Approach for Targeting the Prostaglandin Pathway in Cancer
November 12, 2021 -
PR Newswire
AppliedVR Raises $36 Million Series B To Scale Comprehensive Virtual Reality Platform For Healthcare
November 11, 2021 -
Fierce Healthcare
Former ONC leader Rucker joins interoperability startup 1upHealth
November 10, 2021 -
Reuters
Online medical store PharmEasy targets $842 mln India IPO
November 10, 2021 -
GenomeWeb
Singular Genomics Expands Early-Access Program for New DNA Sequencing Instrument
November 10, 2021 -
GlobeNewswire
Protenus Expands Executive Team With Addition of Experienced Health Tech Leader
November 9, 2021 -
TechCrunch
Notabene raises $10.2M to help crypto exchanges comply with new global regulations
November 8, 2021 -
PR Newswire
Centivo launches integrated virtual advanced primary care offering
November 8, 2021 -
PR Newswire
Innovent Publishes the Preclinical Results of IBI319 (Anti PD-1/CD137 Bispecific Antibody) in Nature Communications
November 7, 2021 -
PR Newswire
Avidity Announces First Person Dosed with an Antibody Oligonucleotide Conjugate (AOC™)
November 4, 2021 -
GlobeNewswire
Adagene Unveils Preclinical Data from Two Transformative Antibody Programs at Upcoming American Society of Hematology (ASH) Annual Meeting
November 4, 2021 -
TechCrunch
Notable, which makes RPA-based tools to speed up healthcare admin, raises $100M at a $600M valuation
November 3, 2021 -
GlobeNewswire
Cytek Biosciences Acquires Tonbo Biosciences’ Cell Analysis Business
November 3, 2021 -
Business Wire
Gundersen Health System Partners with Kyruus to Propel Digital Access Transformation
November 3, 2021 -
TechCrunch
Hone, a human-powered platform for leadership training, announces $16 million Series A funding
November 2, 2021 -
PR Newswire
ABK Biomedical Announces Enrollment Initiation of First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors
November 1, 2021 -
Business Wire
Ensoma Strengthens Scientific Advisory Board with Leaders in Oncology and Primary Immune Deficiencies
October 28, 2021 -
PR Newswire
Innovent and NeoCura Announce Strategic Collaboration to Study the Combination Therapy of Sintilimab and Neoantigen Vaccine NEO_PLIN2101 for Cancer Treatment in China
October 27, 2021 -
GlobeNewswire
Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore
October 27, 2021 -
Forbes
Gig Worker Benefits Platform Stride Health Announces $47 Million In New Funding
October 26, 2021 -
Patina Health
Patina Aims to Profoundly Improve the Healthcare and Aging Experience for People 65+ by Reinventing Primary Care; Announces $50 Million Series A Financing
October 26, 2021 -
Business Wire
ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
October 21, 2021 -
Business Wire
Xilio Therapeutics Announces Pricing of Initial Public Offering
October 21, 2021 -
FierceHealthcare
One Medical launches new program to target chronic care management market
October 19, 2021 -
PR Newswire
Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer
October 19, 2021 -
Sana
Sana Biotechnology Obtains a Non-Exclusive License to CRISPR Cas12b Gene Editing Technology from Beam Therapeutics to Enable Engineered Cell Programs
October 19, 2021 -
PR Newswire
Prime Medicine Announces Addition of Capabilities to Prime Editing Platform
October 19, 2021 -
Business Wire
Vertex Announces Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed With VX-880, a Novel Investigational Stem Cell-Derived Therapy for the Treatment of Type 1 Diabetes
October 18, 2021 -
Business Wire
Mental Health Leader SonderMind Announces Acquisition of Predictive Analytics Platform Qntfy
October 18, 2021 -
Business Wire
Xilio Therapeutics Announces FDA Clearance of Investigational New Drug Application for XTX202 for the Treatment of Solid Tumors
October 18, 2021 -
Business Wire
NFlection Therapeutics Appoints William Hodder as CEO and Expands Leadership Team to Accelerate Development of Targeted Treatments for Rare Diseases
October 18, 2021 -
PR Newswire
FDA Grants Fast Track Designation to AOC 1001 for the Treatment of Myotonic Dystrophy Type 1
October 18, 2021 -
PR Newswire
Innovent Announces ORIENT-31, a Phase 3 Study of Sintilimab in Patients with EGFR-Mutated Nonsquamous Non-Small Cell Lung Cancer with Prior EGFR-TKI Treatment, Has Met Primary Endpoint
October 17, 2021 -
TechCrunch
Funnel, a no-code tool for marketers to organize disparate data sources, raises $66M in ‘pre-IPO’ round
October 13, 2021 -
GlobeNewswire
Cytek® Biosciences Introduces New 25-Color Immunoprofiling Assay
October 7, 2021 -
GlobeNewswire
GeneTx and Ultragenyx Announce First Patient Dosed in Canada in Phase 1/2 Clinical Trial of GTX-102 in Patients with Angelman Syndrome
October 7, 2021 -
Business Wire
Neumora Therapeutics Launches to Pioneer a New Era of Precision Medicines for Brain Diseases
October 7, 2021 -
Business Wire
Atalanta Therapeutics Strengthens Leadership Team with Key Appointments in R&D and Corporate Development
October 7, 2021 -
GlobeNewswire
Affinia Therapeutics Appoints Carole Faig to Board of Directors
October 6, 2021 -
GlobeNewswire
Positive Results of Clinical Trial Comparing Coherus’ Ranibizumab Biosimilar Candidate CHS-201 to Reference Product Lucentis® (Ranibizumab) in the Treatment of Neovascular (Wet) Age-Related Macular Degeneration (nAMD) Presented at Retina Society Annual Scientific Meeting
October 4, 2021 -
PR Newswire
Embark Veterinary Launches First-Ever DNA Test for Purebred Dog Owners
October 4, 2021 -
Business Wire
Firefly Health Launches Health Plan for Employers
October 4, 2021 -
GlobeNewswire
Zenflow Launches Pivotal Clinical Trial of Minimally Invasive Spring® Treatment for Enlarged Prostate Symptoms
October 4, 2021 -
Business Wire
NOCD Expands OCD Awareness Week Programming to Run Throughout October
October 1, 2021